Language: English
Building on the success of the inaugural event, the second edition of the "ESMO Targeted Anticancer Therapies Asia Congress 2026" continues to serve as a key platform in the Asia-Pacific region for showcasing the latest advances in early-phase drug development and precision oncology.
Designed for researchers, clinicians, and industry professionals at the forefront of innovation, the congress offers an exceptional opportunity to explore cutting-edge science, foster cross-disciplinary collaboration, and accelerate the translation of novel therapies into clinical practice. The event brings together global experts and regional leaders to shape the future of targeted anticancer treatment.
